Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsBiochemical and genetic alterations of oxidant/antioxidant status of the brain in rats treated with dexamethasone: protective roles of melatonin and acetyl-L-carnitineLong-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.Chronically elevated glucose compromises myocardial mitochondrial DNA integrity by alteration of mitochondrial topoisomerase function.Glucocorticoid use in acute lymphoblastic leukaemiaAcute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer InstitutAsparaginase-associated toxicity in children with acute lymphoblastic leukemia.Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children With Acute Lymphoblastic Leukemia.Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group.A prospective study of the hypothalamic-pituitary-adrenal axis in children with acute lymphoblastic leukemia receiving chemotherapy.Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia.
P2860
Q28075606-31F98E87-B29E-44F2-B54C-B39CDA39370EQ28572416-0E0CF0C5-820B-49C0-B6CD-3CF79082346FQ34003323-9205D073-46FA-47F8-B417-B986F0FB063FQ34095614-BE78B125-97B2-4D08-A035-8EC8A6624AB0Q34597594-6E3C8A5A-B0D7-4768-86D0-B3E654E0B008Q35844745-B375E46B-92D6-4AF8-905B-147BA4395401Q36064796-55A7B8FB-FD6F-4B0D-BFF4-58A77EE56F71Q36678136-3C768E36-6468-499A-8E10-8C9285FDBB3BQ36762608-069F384E-0F47-4208-860D-C1AD017156B5Q37429718-97A006C8-4EBB-41EC-A61D-A8D20DE771D7Q38883414-90F31CE9-07A4-4552-BE54-1CF4FA66E50BQ39873557-BB508459-46AB-4383-AECD-F172ABEE1615Q42467301-1BC79465-5B66-430C-ACC8-A99ACA5E235CQ46543487-C5E413A5-3F32-40B8-8AAB-89D9AEC0DA7EQ47184318-29A52D72-3C1E-46C6-973D-25EE3C01B9E2Q48059882-DEF10FD3-7BF2-4626-8958-0643248501C4
P2860
Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Dexamethasone-associated toxic ...... concurrent use of daunomycin.
@en
Dexamethasone-associated toxic ...... concurrent use of daunomycin.
@nl
type
label
Dexamethasone-associated toxic ...... concurrent use of daunomycin.
@en
Dexamethasone-associated toxic ...... concurrent use of daunomycin.
@nl
prefLabel
Dexamethasone-associated toxic ...... concurrent use of daunomycin.
@en
Dexamethasone-associated toxic ...... concurrent use of daunomycin.
@nl
P2093
P921
P356
P1433
P1476
Dexamethasone-associated toxic ...... concurrent use of daunomycin.
@en
P2093
AbdulRahman Al-Musa
Abdullah Al-Jefri
Asim F Belgaumi
Hassan El-Solh
Layla Osman
Mahasen Saleh
Mohammed Al-Bakrah
Mohammed Al-Mahr
Mohammed F Salim
Mohammed Osman
P304
P356
10.1002/CNCR.11390
P407
P577
2003-06-01T00:00:00Z